<DOC>
	<DOCNO>NCT02755220</DOCNO>
	<brief_summary>This study aim evaluate safety effectiveness Cingularbio® heart valve Aortic Valve Replacement Mitral Valve Replacement Chinese population</brief_summary>
	<brief_title>Cingularbio® Heart Valve Clincial Study</brief_title>
	<detailed_description>single arm , 12 month follow , mutile center , assess safety effectiveness Cingularbio® heart valve Aortic Valve Replacement Mitral Valve Replacement patient</detailed_description>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>1. age old 60 , less 85 2. patient New York Heart Association ( NYHA ) score less IV 3 . Diangosed admintted heart valve replacement 1. experienced heart valved implantation contraindicate 2. patient experience another tricuspid valve replacement and/or coronary artery bypass graft ( CABG ) 3. patient active endocardium</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>